Clinical study of veralipride in menopausal sudden flushes (author's transl)

A double-blind clinical study was conducted to compare the therapeutic activity of veralipride and placebo in menopausal sudden flushes. Comparison of final numerical rate showed a statistical significant superiority for veralipride. Tolerance was excellent and no significant difference was observed...

Full description

Saved in:
Bibliographic Details
Published inLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris Vol. 56; no. 37-38; p. 1465
Main Authors Wesel, S, L'Hermite, M
Format Journal Article
LanguageFrench
Published France 15.10.1980
Subjects
Adult
Blood Cell Count
Climacteric - drug effects
Clinical Trials as Topic
Creatinine - blood
Double-Blind Method
Female
Humans
Menopause - drug effects
Middle Aged
Sulpiride - adverse effects
Sulpiride - analogs & derivatives
Sulpiride - pharmacology
Sulpiride - therapeutic use
Transaminases - blood
Online AccessGet more information

Cover

More Information
Summary:A double-blind clinical study was conducted to compare the therapeutic activity of veralipride and placebo in menopausal sudden flushes. Comparison of final numerical rate showed a statistical significant superiority for veralipride. Tolerance was excellent and no significant difference was observed between clinical side effects, or biological parameters studied (blood counts and differential, and blood bilirubin, transaminases, glucose, cholesterol, or creatinine levels) in the two groups.